Loading blog post…
A complete guide to thyroid-related hair loss — how both hypothyroidism and hyperthyroidism disrupt the hair cycle, the presentation and timeline of thyroid hair loss, what labs to check, what to expect during treatment, and the common scenario of hair loss persisting after thyroid levels normalize.
· By MedSpot Editorial · 7 min read
Thyroid disorders are among the most common causes of diffuse hair loss in women — and one of the most important to identify because the hair loss is potentially fully reversible if the underlying thyroid dysfunction is corrected. Both underactive and overactive thyroid cause hair loss through distinct mechanisms, and each follows a different timeline. Here's the complete guide.
Thyroid hormones — primarily triiodothyronine (T3) and thyroxine (T4) — regulate the rate of cellular metabolism throughout the body. Hair follicles are directly responsive to thyroid hormone through thyroid hormone receptors expressed in dermal papilla cells and keratinocytes.
Thyroid hormone in normal follicular function:
Both deficiency and excess of thyroid hormone disrupt these regulatory functions — though through different mechanisms and with different clinical presentations.
Hypothyroidism (underactive thyroid; most commonly Hashimoto's thyroiditis, an autoimmune condition) produces insufficient thyroid hormone. In the follicle:
Net result: Increased shedding (telogen effluvium pattern) + potentially thinner, coarser individual hair shafts.
Distribution: Diffuse — thinning across the entire scalp, not patchy. The lateral third of the eyebrows (the "Hertoghe sign") is classically described as an additional finding in hypothyroidism — outer eyebrow thinning. Not specific, but when present alongside scalp thinning, adds to the diagnostic picture.
Associated symptoms (hypothyroidism):
Hair characteristics in hypothyroidism:
Subclinical hypothyroidism — defined as elevated TSH with normal free T4 — is a common finding. Its relationship to hair loss is more debated: some women with subclinical hypothyroidism and hair loss improve with levothyroxine treatment; others do not. The decision to treat subclinical hypothyroidism for hair loss specifically should be made with an endocrinologist weighing the full clinical picture.
Hyperthyroidism (overactive thyroid; most commonly Graves' disease, an autoimmune condition) produces excess thyroid hormone. The mechanism of hair loss differs from hypothyroidism:
Distribution: Also diffuse — similar pattern to hypothyroidism (TE-type shedding).
Associated symptoms (hyperthyroidism):
Hair characteristics in hyperthyroidism:
Postpartum thyroiditis affects approximately 5–10% of women in the year after delivery. It follows a classic pattern:
In the context of postpartum hair loss — which already peaks at months 3–4 due to estrogen withdrawal — concurrent postpartum thyroiditis can significantly worsen and prolong the shedding. Checking TSH at 3–4 months postpartum is appropriate when shedding is severe or prolonged.
| Test | What it measures | Clinical use |
|---|---|---|
| TSH (thyroid-stimulating hormone) | Pituitary signal; most sensitive indicator of thyroid status | First-line screening; elevated in hypothyroidism, suppressed in hyperthyroidism |
| Free T4 | Unbound circulating thyroxine | Confirms hypothyroidism (low T4) or overt disease |
| Free T3 | Unbound triiodothyronine | Sometimes useful in T3-predominant hyperthyroidism |
| Anti-TPO antibodies (anti-thyroid peroxidase) | Autoimmune thyroid disease marker | Positive in Hashimoto's and often in Graves' |
| Anti-TSH receptor antibodies (TRAb) | Graves' disease-specific | Positive in Graves' |
Normal range: Approximately 0.4–4.0 mIU/L (varies by laboratory)
Levothyroxine (synthetic T4): The standard treatment. Dose is titrated to normalize TSH, typically targeting TSH in the lower half of the normal range (0.5–2.5 mIU/L) for most patients.
Hair response timeline:
Options include: antithyroid medications (methimazole, propylthiouracil), radioactive iodine ablation, or thyroidectomy, depending on the cause and severity. Hair recovery follows normalization of thyroid levels.
Hair response timeline (similar pattern to hypothyroidism):
A significant subset of patients experience persistent hair loss even after thyroid levels have been normalized on treatment. This is one of the most frustrating situations in thyroid-related hair loss.
1. Insufficient time: The hair cycle lag means normalization of thyroid function does not produce immediate visible improvement. Patients who check at 3 months and see no change are often within the expected recovery window — evaluation at 6–12 months is more informative.
2. Concurrent androgenetic alopecia: AGA may have been masked by the thyroid condition or may have progressed during the period of thyroid dysfunction. AGA is not reversed by thyroid correction. Dermoscopy showing miniaturized hairs suggests AGA as a co-contributing factor.
3. Concurrent iron deficiency: Hypothyroidism and iron deficiency frequently co-occur (both are common in premenopausal women; hypothyroidism can reduce gastric acid and impair iron absorption; both cause TE). Correcting the thyroid without addressing concurrent low ferritin may leave the hair loss partially uncorrected. Ferritin should be checked alongside thyroid labs.
4. The thyroid level is normalized but not optimal: Some patients have TSH that falls within "normal" (0.4–4.0) but feel and function better at a lower TSH. Hair-relevant thyroid optimization may require TSH in the lower portion of the normal range — a clinical discussion with the treating endocrinologist.
5. Autoimmune cross-reactivity: Hashimoto's thyroiditis and other autoimmune conditions can co-occur with alopecia areata. If shedding becomes patchy rather than diffuse, or does not follow the expected TE pattern, alopecia areata should be considered and evaluated by dermoscopy.
Looking for a hair loss consultation? Browse hair restoration providers on MedSpot →